Edinburg, Texas 78539


Purpose:

The purpose of this research study is to examine the effectiveness of an online Spanish cognitive intervention program in Latino/Hispanic Spanish-speaking subarachnoid hemorrhage patients. In particular, the researchers will examine whether cognitive impairments associated with a subarachnoid hemorrhagic event improve after completing the online cognitive intervention program. Secondary outcomes of the research study include examining whether there is an improvement in research participants' quality of life and psychological functioning as a result of the online Spanish cognitive intervention program.


Study summary:

40 Spanish-speaking research participants who have sustained a subarachnoid hemorrhage in the last 6 months will participate in the current research study. Participants will be randomly assigned to one of two groups: 1) Cognitive intervention group (n = 20) or 2) Control group (n = 20).


Criteria:

Inclusion Criteria: - History of a subarachnoid hemorrhage within the last 6-months. Must be confirmed by medical records and/or neurointerventionist radiologist - 18 years and older - Primarily Spanish-Speaking - Able to read in Spanish - Able to use a computer Exclusion Criteria: - History of neurological conditions (e.g., Alzheimer's disease, epilepsy, traumatic brain injury, brain tumor, encephalitis, meningitis, Parkinson's disease) other than subarachnoid hemorrhage - History of neurodevelopment disorder (e.g., autism spectrum disorders, attention deficit-hyperactivity disorder) - History of learning disabilities - History of psychiatric illness (e.g., depression, anxiety, bipolar disorder, schizophrenia) - Alcohol or illicit substance abuse or dependence - Currently on medication(s) that may impact performance on the neuropsychological evaluation or online cognitive intervention program - Severe expressive aphasia - Upper extremities or vision problems that prevent participant from adequately using a computer or completing the neuropsychological evaluation - Unable to commit to participate for the entire study including returning for one-year follow-up neuropsychological evaluation


NCT ID:

NCT03621397


Primary Contact:

Principal Investigator
Eduardo Estevis, Ph.D.
DHR Health

Eduardo Estevis, Ph.D.
Phone: 956-362-8507
Email: e.estevis@dhr-rgv.com


Backup Contact:

Email: pt.noonan@dhr-rgv.com
Patrick T. Noonan, MD
Phone: 956-362-8500


Location Contact:

Edinburg, Texas 78539
United States

Eduardo Estevis, Ph.D.
Phone: 956-362-8507
Email: e.estevis@dhr-rgv.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.